Pkia - cAMP-dependent protein kinase inhibitor alpha Gene
Species: Rattus norvegicus
Summary
Predicted to enable cAMP-dependent protein kinase inhibitor activity and protein kinase A catalytic subunit binding activity. Predicted to be involved in negative regulation of cAMP-dependent protein kinase activity. Predicted to act upstream of or within negative regulation of nitrogen compound metabolic process; negative regulation of protein import into nucleus; and regulation of G2/M transition of mitotic cell cycle. Predicted to be active in cytoplasm and nucleus. Orthologous to human PKIA (cAMP-dependent protein kinase inhibitor alpha). [provided by Alliance of Genome Resources, Apr 2022]
Pkia Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_053772.2 | NP_446224.1 | cAMP-dependent protein kinase inhibitor alpha |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cAMP-dependent protein kinase inhibitor alpha |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS10598 | PKIA Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service